Subtopic Deep Dive
Hereditary Hemorrhagic Telangiectasia Genetics
Research Guide
What is Hereditary Hemorrhagic Telangiectasia Genetics?
Hereditary Hemorrhagic Telangiectasia (HHT) genetics studies mutations in ENG, ACVRL1, and SMAD4 genes causing autosomal dominant vascular dysplasia with telangiectases and arteriovenous malformations.
HHT1 links to ENG mutations, HHT2 to ACVRL1 mutations, and HHT3/4 to rarer loci including SMAD4 (McDonald et al., 2015, 729 citations). Research maps genotype-phenotype correlations, such as earlier pulmonary AVMs in HHT2 (Govani and Shovlin, 2009, 487 citations). Over 20 papers detail TGF-β/BMP signaling disruptions in endothelial cells (Abdalla and Letarte, 2005, 373 citations).
Why It Matters
Genetic diagnosis via ENG/ACVRL1 sequencing enables presymptomatic screening for AVMs in lungs, liver, and brain, reducing hemorrhage risks (McDonald et al., 2015). Family cascade testing identifies at-risk relatives for early intervention, as in Curacao criteria fulfillment (Govani and Shovlin, 2009). BMP9/ALK1 pathway insights support targeted therapies, overlapping with pulmonary hypertension management (David et al., 2008; Wooderchak-Donahue et al., 2013). Liver vascular guidelines inform HHT hepatic involvement (DeLeve et al., 2008).
Key Research Challenges
Genotype-Phenotype Variability
ENG mutations associate with severe epistaxis but variable AVM penetrance across families (Govani and Shovlin, 2009). ACVRL1 variants show earlier pulmonary AVM onset yet milder telangiectases (McDonald et al., 2011). Modifier genes remain unidentified in most cohorts (Abdalla and Letarte, 2005).
Rare Variant Detection
SMAD4 mutations cause combined HHT-Juvenile Polyposis, but low prevalence hinders diagnostics (McDonald et al., 2015). Novel BMP9 mutations overlap HHT phenotypes, requiring expanded sequencing panels (Wooderchak-Donahue et al., 2013). Functional assays for variants of unknown significance lack standardization (David et al., 2008).
Signaling Pathway Complexity
TGF-β/ALK1 disruptions cause endothelial dysfunction, but downstream effectors vary by tissue (Goumans and ten Dijke, 2017). BMP9 as quiescence factor implicates ligand-receptor imbalances in AVM formation (David et al., 2008). Integrating multi-omics data challenges correlation with clinical outcomes (Harrison et al., 2003).
Essential Papers
Vascular disorders of the liver # †
Laurie D. DeLeve, Dominique Valla, Guadalupe García–Tsao · 2008 · Hepatology · 942 citations
This guideline has been approved by the American Association for the Study of Liver Diseases (AASLD) and represents the position of the association.
Hereditary hemorrhagic telangiectasia: genetics and molecular diagnostics in a new era
Jamie McDonald, Whitney Wooderchak‐Donahue, Chad VanSant Webb et al. · 2015 · Frontiers in Genetics · 729 citations
Hereditary hemorrhagic telangiectasia (HHT) is a vascular dysplasia characterized by telangiectases and arteriovenous malformations (AVMs) in particular locations described in consensus clinical di...
Hereditary haemorrhagic telangiectasia: a clinical and scientific review
Fatima S Govani, Claire L. Shovlin · 2009 · European Journal of Human Genetics · 487 citations
Bone Morphogenetic Protein-9 Is a Circulating Vascular Quiescence Factor
Laurent David, Christine Mallet, Michelle Kéramidas et al. · 2008 · Circulation Research · 405 citations
Angiogenesis is a complex process, requiring a finely tuned balance between numerous stimulatory and inhibitory signals. ALK1 (activin receptor like-kinase 1) is an endothelial-specific type 1 rece...
Hereditary hemorrhagic telangiectasia: An overview of diagnosis, management, and pathogenesis
Jamie McDonald, Pınar Bayrak‐Toydemir, Reed E. Pyeritz · 2011 · Genetics in Medicine · 381 citations
Hereditary haemorrhagic telangiectasia: current views on genetics and mechanisms of disease
S A Abdalla, M Letarte · 2005 · Journal of Medical Genetics · 373 citations
Hereditary haemorrhagic telangiectasia (HHT) is an autosomal dominant disorder characterised by epistaxis, telangiectases, and multiorgan vascular dysplasia. The two major types of disease, HHT1 an...
Molecular and functional analysis identifies ALK-1 as the predominant cause of pulmonary hypertension related to hereditary haemorrhagic telangiectasia
Rachel E. Harrison, J A Flanagan, M Sankelo et al. · 2003 · Journal of Medical Genetics · 355 citations
Background: Mutations of the transforming growth factor β (TGFβ) receptor components ENDOGLIN and ALK-1 cause the autosomal dominant vascular disorder hereditary haemorrhagic telangiectasia (HHT). ...
Reading Guide
Foundational Papers
Start with Abdalla and Letarte (2005, 373 citations) for ENG/ACVRL1 mechanisms; Govani and Shovlin (2009, 487 citations) for clinical-genetic review; McDonald et al. (2011, 381 citations) for diagnostic overview.
Recent Advances
Study McDonald et al. (2015, 729 citations) for molecular diagnostics; Wooderchak-Donahue et al. (2013, 302 citations) for BMP9-HHT overlap; Goumans and ten Dijke (2017, 338 citations) for TGF-β cardiovascular links.
Core Methods
Mutation screening via sequencing panels; BMP9/ALK1 binding assays; pedigree analysis for penetrance; endothelial cell models for signaling (David et al., 2008; Harrison et al., 2003).
How PapersFlow Helps You Research Hereditary Hemorrhagic Telangiectasia Genetics
Discover & Search
Research Agent uses searchPapers('HHT ENG ACVRL1 mutations') to retrieve McDonald et al. (2015, 729 citations), then citationGraph reveals 500+ citing works on genotype-phenotype links and exaSearch uncovers BMP9 overlaps from Wooderchak-Donahue et al. (2013). findSimilarPapers expands to ALK1 pathway papers like David et al. (2008).
Analyze & Verify
Analysis Agent applies readPaperContent on McDonald et al. (2015) to extract mutation databases, verifyResponse with CoVe cross-checks claims against Govani and Shovlin (2009), and runPythonAnalysis parses variant frequencies from supplements using pandas for statistical significance (p<0.05 enrichment in HHT2). GRADE grading scores ENG evidence as high-quality.
Synthesize & Write
Synthesis Agent detects gaps in SMAD4 modifier research via contradiction flagging across Abdalla and Letarte (2005) and recent citations; Writing Agent uses latexEditText for genotype tables, latexSyncCitations for 20+ refs, and latexCompile to generate polished reviews with exportMermaid for TGF-β signaling diagrams.
Use Cases
"Compute allele frequency differences for ENG vs ACVRL1 mutations in HHT cohorts from supplements."
Research Agent → searchPapers → Analysis Agent → readPaperContent (McDonald 2015) → runPythonAnalysis (pandas groupby, t-test on variant tables) → CSV export of p-values and odds ratios.
"Draft a LaTeX review section on HHT genotype-phenotype correlations with citations."
Synthesis Agent → gap detection → Writing Agent → latexEditText (insert correlations from Govani 2009) → latexSyncCitations (Abdalla 2005 et al.) → latexCompile → PDF with figure legends.
"Find code for simulating ALK1-BMP9 signaling in HHT models."
Research Agent → searchPapers('HHT ALK1 simulation') → paperExtractUrls → paperFindGithubRepo → githubRepoInspect (runPythonAnalysis on endothelial network models from David 2008 citations) → validated script output.
Automated Workflows
Deep Research workflow scans 50+ HHT papers via citationGraph from McDonald et al. (2015), producing structured reports on mutation spectra with GRADE scores. DeepScan's 7-step chain verifies TGF-β claims (Goumans 2017) against primaries using CoVe checkpoints. Theorizer generates hypotheses on BMP9 modifiers from Wooderchak-Donahue et al. (2013) literature synthesis.
Frequently Asked Questions
What is the definition of HHT genetics?
HHT genetics examines ENG, ACVRL1, and SMAD4 mutations causing vascular malformations via TGF-β pathway disruption (McDonald et al., 2015).
What are main methods in HHT genetic research?
Sanger/next-gen sequencing identifies mutations; functional assays test ALK1/BMP9 signaling; genotype-phenotype studies use Curacao criteria cohorts (Govani and Shovlin, 2009; David et al., 2008).
What are key papers on HHT genetics?
McDonald et al. (2015, 729 citations) reviews diagnostics; Abdalla and Letarte (2005, 373 citations) details ENG/ACVRL1 mechanisms; Wooderchak-Donahue et al. (2013, 302 citations) links BMP9 mutations.
What open problems exist in HHT genetics?
Unidentified modifiers explain phenotype variability; rare variants need functional validation; tissue-specific signaling requires multi-omics integration (Goumans and ten Dijke, 2017).
Research Vascular Anomalies and Treatments with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Hereditary Hemorrhagic Telangiectasia Genetics with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers
Part of the Vascular Anomalies and Treatments Research Guide